Become a Chimera Research Group Subscriber
If you like what you've seen at BiotechDueDiligence, then you may be interested in Chimera Research Group. This biopharmaceutical research firm combines the interdisciplinary insights of each team member to provide in-depth, expert, peer-reviewed, and actionable insights, ideas and reports related biotech and pharma investing.
Intrigued? Learn more about the many benefits of Chimera Research Group membership and JOIN TODAY!
Intrigued? Learn more about the many benefits of Chimera Research Group membership and JOIN TODAY!
Synta Pharma $SNTA - Insider and Institutional Ownership
- This page will help track significant ownership of the company by insiders and institutions, as well as changes in this positions
- Note: as of 9/30/2011 there were 49,498,350 shares of common stock outstanding
- Click here to access institutional holdings database from NASDAQ
- Click here to access insider transactions (SEC form 4) from NASDAQ
- Click here for SNTA 2011 Proxy statement reflecting insider stock and option positions as of 3/1/2011